🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMarketplace & ListingsTelehealth prescriber directory — by state and medication

Telehealth prescriber directory — by state and medication

TomTeleRx Sat, Jun 6, 2026 at 2:33 PM 8 replies 172 viewsPage 1 of 2
TomTeleRx
Member
189
678
Feb 2025
Delaware
Jun 6, 2026 at 2:33 PM#1

A reference post rather than a discussion. Corrections are the point; I would rather this be right than mine. It is about cost and coverage, and it is deliberately narrow — everything I am not confident about is marked as such.

What is actually established

Denials are usually procedural rather than clinical, and the order that works reflects that. Get the denial reason in writing, because it names the criterion you failed. Then supply the documentation that criterion asks for — usually documented BMI with a comorbidity, or a failed prior therapy. Then appeal, and ask for a peer-to-peer review, because a prescriber talking to a reviewing clinician resolves a large fraction of denials that written appeals do not. Manufacturer copay assistance is separate and applies mainly to commercial insurance, and patient assistance programmes are means-tested rather than a discount.

The condition it depends on

Coverage criteria are plan-specific rather than insurer-specific. Two people with the same insurer and different employers have different rules, which is why "my insurer covers it" is not transferable information.

What I am not sure about

The narrow version of the question is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

— TomTeleRx · corrections welcome and will be edited into this post with credit
21 16pete_manc_UK, anna.melb_AU, mark_tokyo and 18 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Jun 6, 2026 at 2:58 PM#2
TomTeleRx said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $284/month (eating less)
  • Restaurants: SAVED $174/month (fewer meals out)
  • Alcohol: SAVED $124/month (stopped drinking)
  • Life insurance: Premium REDUCED by $34/month (lower BMI)
  • Copays: SAVED $64/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

20 15AmyNC_wife, SkepticalSean, Dr.CardioMD and 17 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jun 6, 2026 at 3:23 PM#3
TomTeleRx said:
Denials are usually procedural rather than clinical, and the order that works reflects that.

I read this differently from TomTeleRx, on substance rather than tone. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

Last edited: Jun 6, 2026 at 4:23 PM
19 14LindaRN_retired, tommy_boulder, hyun_seoul and 16 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Jun 6, 2026 at 3:48 PM#4
Dr.PeteFamMed said:
The affordability discussion here usually stops at individual tactics.
Dr.PeteFamMed said:
...compounded vs brand cost and coverage...

This debate comes up weekly and I think both sides have valid points:

Pro-brand: FDA-approved, manufacturing standards guaranteed, clinical trial data directly applicable

Pro-compounded: 10x cost savings, same active molecule, independent testing available, accessibility

My position: if you can afford brand or have insurance coverage, that's the gold standard. If not, properly tested compounded from a 503B pharmacy is a reasonable alternative. Neither side should shame the other.

18 13FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 15 others
Reply Quote Save Share Report
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Jun 6, 2026 at 6:02 PM#5
RetaRick_CA said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $284/month (eating less) Restaurants: SAVED $174/month…

Adding a me-too, because a thread of one person's experience is not much use. The detail I would add is minor and it is already implied above.

Last edited: Jun 6, 2026 at 8:02 PM
17 12gary_naperville, sean_dublin, hannah_MT and 14 others
Reply Quote Save Share Report

Similar Threads

Price comparison: compounded semaglutide — June 202622 replies
Telehealth provider directory — updated quarterly5 replies
Group buy discussion — is it worth organizing?3 replies
Bacteriostatic water sourcing guide — verified suppliers3 replies
Compounded semaglutide price tracker — updated weekly19 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register